In patient-derived glioblastoma cells and orthotopic glioblastoma mouse models, Noch et al. [169] found that reducing insulin feedback with metformin and a ketogenic diet improves the treatment efficacy of PI3K inhibitors, given that PI3K inhibition induces hyperglycemia and hyperinsulinemia in mice. Here, INS is linked to glioblastoma.